TRNDi008-A

Registration Summary:

A P E C

iPSC HT525A

The cell line is not submitted yet.

(only basic data is shown)

General

iPSC Line
hPSCreg name	TRNDi008-A
Cite as:	TRNDi008-A (RRID:CVCL_UL28)
Alternative name(s)	iPSC HT525A
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	27th March 2019
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	NIH/NCATS-TRND Branch (TRND)
External iPSC Databases
Cellosaurus	CVCL_UL28
Wikidata	Q98133597
General iPSC Information
Publications	Hong J et al. Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene. Stem cell research. 2019 May;37:101451. Patterson K et al. Generation of two induced pluripotent stem cell lines (NHLBIi001-A and NHLBIi001-B) from a healthy Caucasian female volunteer with normal cardiac function. Stem cell research. 2019 Dec;41:101627. Patterson K et al. Generation of two tdTomato reporter induced pluripotent stem cell lines (NHLBIi003-A-1 and NHLBIi003-A-2) by AAVS1 safe harbor gene-editing. Stem cell research. 2020 Jan;42:101673. D'Avanzo F et al. Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment. International journal of molecular sciences. 2020 Feb 13;21(4). Hong J et al. iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II. Experimental cell research. 2022 Mar 1;412(1):113007. Gaudioso Á et al. Models to study basic and applied aspects of lysosomal storage disorders. Advanced drug delivery reviews. 2022 Nov;190:114532.

iPSC Derivation

General